Asymptomatic Volunteers with a Polycystic Ovary Are a Functionally Distinct but Heterogeneous Population

被引:53
作者
Mortensen, Monica [1 ]
Ehrmann, David A. [1 ]
Littlejohn, Elizabeth [1 ]
Rosenfield, Robert L. [1 ]
机构
[1] Univ Chicago, Sect Adult & Pediat Endocrinol Diabet & Metab, Pritzker Sch Med, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
GONADOTROPIN-RELEASING-HORMONE; NORMAL WOMEN; INSULIN; HYPERANDROGENISM; RESPONSES; COMMON; ADOLESCENTS; MORPHOLOGY; SECRETION; PHENOTYPE;
D O I
10.1210/jc.2008-2771
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context/Objective: Our objective was to determine the ovarian function of asymptomatic volunteers with a polycystic ovary (V-PCO). Participants: Non-hirsute eumenorrheic V-PCO (n = 32) and volunteers with ultrasonographically normal ovaries (V-NO) (n = 21) were compared with one another and with polycystic ovary syndrome (PCOS) patients who met National Institute of Health criteria (n = 90). Design/Setting/Interventions: GnRH agonist (GnRHag), ACTH, and oral glucose tolerance tests were prospectively performed in a General Clinical Research Center. Results: The distribution of 17-hydroxyprogesterone (17OHP) responses to GnRHag of V-PCO formed a distinct population intermediate between that of V-NO, the reference population, and PCOS. Nevertheless, the V-PCO population was heterogeneous. There were 53% (seventeen of 32) that were functionally normal, with 17OHP responses and free testosterone levels like V-NO. A total of 25% (eight of 32) had an elevated free testosterone, thus meeting Rotterdam criteria for PCOS; one third of these had 17OHP hyperresponsiveness to GnRHag testing. The remaining 22% (seven of 32) had 17OHP hyperresponsiveness to GnRHag, but normal free testosterone. Of PCOS, 69% had elevated 17OHP hyperresponsiveness to GnRHag. Ovarian volume correlated significantly with 17OHP responses only in PCOS, accounting for just 10% of the variance. Conclusions: Many asymptomatic volunteers have a PCO. They are a distinct, but heterogeneous, population with respect to ovarian function, ranging from normal (53%) to occult PCOS by Rotterdam criteria (25%). Nearly one quarter (22%) had the typical PCOS type of ovarian dysfunction without hyperandrogenemia, termed a "dysregulated PCO"; they or their offspring may be at risk for PCOS. Ovarian ultrasonographic characteristics must be considered when establishing norms for ovarian function. (J Clin Endocrinol Metab 94: 1579-1586, 2009)
引用
收藏
页码:1579 / 1586
页数:8
相关论文
共 35 条
[1]
ADAMS J, 1985, LANCET, V2, P1375
[2]
Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome [J].
Adams, JM ;
Taylor, AE ;
Crowley, WF ;
Hall, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4343-4350
[3]
Altman DG., 1996, PRACTICAL STAT MED R, V7th
[4]
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[5]
Ultrasound assessment of the polycystic ovary: international consensus definitions [J].
Balen, AH ;
Laven, JSE ;
Tan, SL ;
Dewailly, D .
HUMAN REPRODUCTION UPDATE, 2003, 9 (06) :505-514
[6]
A quantitative scale of acanthosis nigricans [J].
Burke, JP ;
Hale, DE ;
Hazuda, HP ;
Stern, MP .
DIABETES CARE, 1999, 22 (10) :1655-1659
[7]
EVIDENCE FOR A SINGLE GENE EFFECT CAUSING POLYCYSTIC OVARIES AND MALE PATTERN BALDNESS [J].
CAREY, AH ;
CHAN, KL ;
SHORT, F ;
WHITE, D ;
WILLIAMSON, R ;
FRANKS, S .
CLINICAL ENDOCRINOLOGY, 1993, 38 (06) :653-658
[8]
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro [J].
Carlsson, I. B. ;
Scott, J. E. ;
Visser, J. A. ;
Ritvos, O. ;
Themmen, A. P. N. ;
Hovatta, O. .
HUMAN REPRODUCTION, 2006, 21 (09) :2223-2227
[9]
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[10]
Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing [J].
Chang, PL ;
Lindheim, SR ;
Lowre, C ;
Ferin, M ;
Gonzalez, F ;
Berglund, L ;
Carmina, E ;
Sauer, MV ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :995-1000